The math is brutal: 120,000 Americans on the transplant waiting list, but only ~40,000 organs available each year. The US transplantation market report by MRFR shows that kidneys are the most transplanted organ, but the liver is the fastest‑growing segment. The market is $4.13 billion and will hit $11.21 billion by 2035, growing at 9.5% CAGR. Why? Because hepatitis C cures and better anti‑rejection drugs are expanding the donor pool.

Deceased donor transplantation still dominates — it's the traditional model. But living donor transplantation is the fastest‑growing. The US transplantation market analysis highlights that paired kidney exchanges now allow incompatible pairs to swap, dramatically increasing living donation. And new laparoscopic techniques make donor surgery safer, with faster recovery.

What's the bottleneck? Not just organs — also logistics. Organs can only survive 4‑36 hours outside the body. That's why preservation technology (cold storage, machine perfusion) is a hot R&D area.

The bottom line: if you need a transplant, get listed early, stay healthy, and consider a living donor. The wait is long, but new technologies are chipping away at the shortage.